Mass Balance Study of [14C]LC350189 in Healthy Volunteers
Status:
Completed
Trial end date:
2020-03-07
Target enrollment:
Participant gender:
Summary
This is a Phase 1, open-label, single-dose, mass balance study designed to evaluate the
absorption, metabolism, and excretion of [14C] radiolabeled LC350189 after oral
administration.